Recent advances in juvenile dermatomyositis
Tóm tắt
This paper reviews the knowledge we continue to gain in the areas of pathogenesis, evaluation of disease activity, and interventional strategies with regards to idiopathic inflammatory myositis. Potential new diagnostic criteria incorporate the use of magnetic resonance imaging and other imaging modalities along with the use of muscle biopsy pathologic features including that of immunologic markers. Specifically, this criterion reflects the upregulation of major histocompatibility complex molecules on muscle tissue during acute inflammation.
Tài liệu tham khảo
Li CK, Varsani H, Holton JL, et al.: MHC Class I overexpression on muscles in early juvenile dermatomyositis. J Rheumatol 2004, 31:605–609.
McDouall RM, Dunn MJ, Dubowitz V: Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci 1989, 89:213–226.
Sallum AM, Marie SK, Wakamatsu A, et al.: Immunohisto-chemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis. J Rheumatol 2004, 31:801–807.
Abramson LS, Albertini RJ, Pachman LM, Finette BA: Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis. J Rheumatol 2004, 31:801–807.
Reed AM, Cragoe S, Strausbach M, et al.: Skewed T-cell receptor repertoire in children with juvenile dermatomyositis. Arthritis Rheum 2001, 44:S292.
Mizuno A, Yachie S, Nagaoki H, et al.: Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T Cells with killer/effector phenotypes in juvenile dermatomyositis syndrome K. Clin Exp Immunol 2004, 137:1365–2249.
Reed AM, McNallan K, Wettstein P, et al.: Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis? J Immunol 2004, 172:5041–5046.This article is the first to show chimeric cell responsiveness to self.
Huber AM, Feldman BM, Rennebohm RM, et al.: Validation and clinical significance of the childhood myositis assessment scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004, 50:1595–1603.Significant work is attempting to define the assessments used in IIM. This article summarizes a large undertaking of such efforts.
Rennebohm RM, Jones K, Huber AM, et al.: Normal scores for nine maneuvers of the childhood myositis assessment scale. Arthritis Rheum 2004, 51:365–370.
Rider LG, Giannini EH, Brunner HI, et al.: International myositis Assessment and Clinical Studies Group international consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004, 50:2281–2290.
Maillard SM, Jones R, Owens C, et al.: Quantitative assessment of MRIT2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford) 2004, 43:603–608.
Drinkard BE, Hicks J, Danoff J, Rider LG: Fitness as a determinant of the oxygen uptake /work rate slope in healthy children and children with inflammatory myopathy. Can J Appl Physiol 2003, 28:888–897.
Lohmann Siegel K, Hicks JE, Koziol DE, et al.: Walking ability and its relationship to lower-extremity muscle strength in children with idiopathic inflammatory myopathies. Arch Phys Med Rehabil 2004, 85:767–771.
Riley P, Maillard SM, Wedderburn LR, et al.: Pilkington intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety. Rheumatology (Oxford) 2004, 43:491–496.